I-care: Stimulating Self-management in Patients With Type 2-diabetes
I-care
1 other identifier
interventional
15
1 country
1
Brief Summary
The overall objective of this pilot study is to develop a cost-effective treatment methodology delivered outside of traditional clinical setting, and based on modern technology for patients with diabetes type 2 also suffering from obesity. This study will investigate the feasibility of web based counselling and situational feedback through mobile supervising. The intention is to treat 10-15 patients. All participants will receive standard treatment delivered by their general practitioners. In addition the participants will fill in and send diaries to the supervisors each evening for 4 weeks reduced to a weekly frequency for the next two months period. The diary's schedule will be an evaluation of the day activities related to meals and food, medication management as well as the performed physical activities. The diary's schedule will also include blood glucose sample, and plans for the next day especially regarding physical activity. The participants will be able to view their own registrations on a web page. Daily/weekly situational feedback will be given to the participants within a cognitive behavioural framework to stimulate self-management. The primary outcome will be the HbA1c levels. Secondary outcomes will include evaluation of lifestyle outcomes such as physical activity levels and eating behaviour, and skills such as self-management of medication. In addition, the interventions effectiveness will examine mental health outcomes such as emotional distress and health-related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 15, 2011
CompletedFirst Posted
Study publicly available on registry
February 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedSeptember 24, 2018
September 1, 2018
5.3 years
February 15, 2011
September 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood glucose control with changes in Glycated hemoglobin (HbA1c) values
HBA1c is a form of hemoglobin used primarily to identify the average plasma glucose concentration over prolonged periods of time. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose. Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous months prior to the measurement
At the baseline and at the end of the intervention (3 months)
Secondary Outcomes (4)
Health Education Impact Questionnaire (heiQ);
At the baseline and after the end of the intervention (3 months)
Problem Areas in Diabetes (PAID)
At the baseline and after the end of the intervention (3 months)
Food frequency questionnaire FFQ
At the baseline and after the end of the intervention (3 months)
Audit of Diabetes Dependence Quality of Life (ADDQoL-19)
At the baseline and after the end of the intervention (3months)
Study Arms (1)
Lifestyle counseling
EXPERIMENTALInterventions
All patients will receive standard care (reassurance, education, physiotherapy, and necessary medication). Complementary to this standard care, the participants will be required to closely monitor their blood glucose levels, weight, eating behavior and daily activities, and to relay this information to the nurse specialist trained in treating somatic patients with CBT. The nurse will then suggest appropriate treatment decisions, the patients will receive situational feedback based on the electronic diary during 3 months (daily during 4 weeks intensive treatment and weekly during 2 months as a complement).
Eligibility Criteria
You may qualify if:
- age 18-70 years old
- T2DM diagnosed \> 3 months prior to study
- HbA1c 7,5-10%
- capability of filling in Norwegian questionnaires
- BMI ≥ 25
- able and willing to give signed informed consent
- willing to attend the full treatment schedule including ability to use mobile phones, computers and pocket computers
You may not qualify if:
- change in weight \> 5kg during the last 3 months
- any mental or physical condition interfering with the protocol
- not having easy access to computers
- having reading problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo Metropolitan Universitylead
- University of Oslocollaborator
Study Sites (1)
Oslo College University
Oslo, Arkeshus, 0130, Norway
Related Publications (1)
Nes AAG, van Dulmen S, Brembo EA, Eide H. An mHealth Intervention for Persons with Diabetes Type 2 Based on Acceptance and Commitment Therapy Principles: Examining Treatment Fidelity. JMIR Mhealth Uhealth. 2018 Jul 3;6(7):e151. doi: 10.2196/mhealth.9942.
PMID: 29970357DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andréa AG Nes, Mc
Oslo College University
- PRINCIPAL INVESTIGATOR
Hilde Eide, Professor
Oslo College University/Buskerud College University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2011
First Posted
February 16, 2011
Study Start
April 1, 2010
Primary Completion
July 1, 2015
Study Completion
December 1, 2015
Last Updated
September 24, 2018
Record last verified: 2018-09